Prime Capital Investment Advisors, LLC Corcept Therapeutics Inc Transaction History
Prime Capital Investment Advisors, LLC
- $7.33 Billion
- Q2 2025
A detailed history of Prime Capital Investment Advisors, LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Prime Capital Investment Advisors, LLC holds 2,948 shares of CORT stock, worth $216,943. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,948
Previous 2,964
0.54%
Holding current value
$216,943
Previous $338,000
36.09%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding CORT
# of Institutions
468Shares Held
83.3MCall Options Held
1.12MPut Options Held
2.54M-
Black Rock Inc. New York, NY16.5MShares$1.22 Billion0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.68MShares$712 Million0.01% of portfolio
-
Ingalls & Snyder LLC New York, NY7.72MShares$568 Million20.11% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.27MShares$461 Million0.65% of portfolio
-
Parallel Advisors, LLC3.87MShares$285 Million5.83% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $7.88B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...